Ankylosing spondylitis and Klebsiella

Ankylosing spondylitis and Klebsiella is a comprehensive and informative text on the cause of Ankylosing spondylitis. Ankylosing spondylitis (AS) is a condition which affects 20 million people worldwide and is likely caused or initiated by a bowel infection from Klebsiella bacteria. When a patient...

Full description

Bibliographic Details
Main Author: Ebringer, Alan. (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic
Language:English
Published: London : Springer London : Imprint: Springer, 2013.
Subjects:
Online Access:View fulltext via EzAccess
LEADER 04288nam a22003975i 4500
001 12517
003 DE-He213
005 20130727041238.0
007 cr nn 008mamaa
008 121116s2013 xxk| s |||| 0|eng d
020 # # |a 9781447143000  |9 978-1-4471-4300-0 
024 7 # |a 10.1007/978-1-4471-4300-0  |2 doi 
050 # 4 |a RC927-927.5 
072 # 7 |a MJM  |2 bicssc 
072 # 7 |a MED083000  |2 bisacsh 
082 0 4 |a 616.723  |2 23 
100 1 # |a Ebringer, Alan.  |e author. 
245 1 0 |a Ankylosing spondylitis and Klebsiella  |c by Alan Ebringer.  |h [electronic resource] / 
264 # 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2013. 
300 # # |a XX, 256 p. 89 illus., 86 illus. in color.  |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
505 0 # |a Ankylosing spondylitis as a scientific problem -- History of the origin of ankylosing spondylitis -- The discovery of HLA-B27 in ankylosing spondylitis and related disorders -- Molecular mimicry between HLA-B27 and Klebsiella bacteria investigated by using rabbit antisera -- Molecular mimicry between HLA-B27 and Klebsiella bacteria investigated by using human tissue typing sera -- Muscle changes in ankylosing spondylitis -- Raised serum IgA is present in ankylosing spondylitis patients -- Faecal cultures in ankylosing spondylitis and uveitis -- Biochemical parameters and Klebsiella in ankylosing spondylitis -- Binding of Klebsiella antisera to HLA-B27 cells -- IgA antibodies to Klebsiella and other Gram-negative bacteria in ankylosing spondylitis -- IgA antibodies to Klebsiella measured by immunoblotting -- Antibodies to Klebsiella in ankylosing spondylitis measured by bacterial agglutination and ELISA against lipopolysaccharides -- Dutch and German patients with ankylosing spondylitis have antibodies to Klebsiella -- Spanish, Finnish and Swedish patients with ankylosing spondylitis have antibodies to Klebsiella -- Molecular mimicry between Klebsiella pullulanase enzyme, HLA-B27 and collagens I and IV -- Antibodies to Klebsiella and HLA-B27 peptides in ankylosing spondylitis patients from southern Japan -- Ankylosing spondylitis sera are cytotoxic to cells bearing HLA-B27 sequences -- Pathogenesis of ankylosing spondylitis and Klebsiella substrates -- Ankylosing spondylitis and the low starch diet -- The problem of Crohn s disease and Klebsiella -- Ankylosing spondylitis and Popper sequences . 
520 # # |a Ankylosing spondylitis and Klebsiella is a comprehensive and informative text on the cause of Ankylosing spondylitis. Ankylosing spondylitis (AS) is a condition which affects 20 million people worldwide and is likely caused or initiated by a bowel infection from Klebsiella bacteria. When a patient is infected by Klebsiella bacteria, his or her immune system will make antibodies against all the antigens or molecules found in the microbe. Because some of the bacterial antigens resemble self tissues, the anti-bacterial antibodies will attack not only the bacteria but also the self tissues such as the joints and the cells having the same HLA molecules, which is how the disease AS starts. This is the concept of molecular similarity or molecular mimicry which previously has been found to work in two other autoimmune diseases; rheumatic fever and rheumatoid arthritis. The first paper on this subject was published in 1976 and since then over 100 papers on rheumatological topics have been published, from Prof Ebringer s group, at the Division of Life Sciences, King s College in London, UK. The relevant information from these papers is extracted and presented in this book format making it accessible to health professionals, research institutions, pharmaceutical companies and universities and the general public.  
650 # 0 |a Medicine. 
650 # 0 |a Rheumatology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Rheumatology. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781447142997 
856 4 0 |z View fulltext via EzAccess  |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4471-4300-0 
912 # # |a ZDB-2-SME 
950 # # |a Medicine (Springer-11650)